PDT Partners’s Cumberland Pharmaceuticals CPIX Stock Holding History

PDT Partners’s Portfolio CPIX Stock Details CPIX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-15,146	Closed	-$68K	–	465
2016 Q1	$68K	Sell	15,146 -10,488	-41%	-$50K	﹤0.01%	551
2015 Q4	$135K	Sell	25,634 -9,800	-28%	-$55.8K	0.02%	366
2015 Q3	$204K	Sell	35,434 -1,200	-3%	-$7.48K	﹤0.01%	1152
2015 Q2	$262K	Buy	36,634 +4,600	+14%	+$32K	0.01%	1169
2015 Q1	$213K	Hold	32,034	–	–	0.01%	1256
2014 Q4	$192K	Hold	32,034	–	–	0.02%	573
2014 Q3	$158K	Hold	32,034	–	–	﹤0.01%	1212
2014 Q2	$144K	Hold	32,034	–	–	﹤0.01%	1345
2014 Q1	$144K	Hold	32,034	–	–	﹤0.01%	1262
2013 Q4	$164K	Buy	32,034 +1,700	+6%	+$8.3K	0.02%	599
2013 Q3	$137K	Hold	30,334	–	–	﹤0.01%	1435
2013 Q2	$155K	Buy	+30,334	New	+$151K	﹤0.01%	1405

Other funds holding CPIX

Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $71.6B AUM 29.66% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

SCM

Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return

Bard Associates Chicago, Illinois $398M AUM 54.32% 1-Year Est. Return

PDT Partners's CPIX Position: Q2 2016 in Review

PDT Partners sold out of Cumberland Pharmaceuticals (CPIX) in Q2 2016, closing a stake of 15,146 shares — an estimated $68K sold.

PDT Partners first reported a position in CPIX in Q2 2013 and held it in 12 quarters. The position peaked at $262K in Q2 2015. 44 funds tracked by Wall St. Rank hold CPIX as of Q2 2016.

PDT Partners reported no remaining Cumberland Pharmaceuticals position as of Q2 2016 after selling out during the quarter.
PDT Partners sold 15,146 Cumberland Pharmaceuticals shares in Q2 2016, an estimated $68K.
PDT Partners first reported a position in Cumberland Pharmaceuticals in Q2 2013 and held it in 12 quarters.
PDT Partners's Cumberland Pharmaceuticals position peaked at $262K in Q2 2015.
44 funds tracked by Wall St. Rank held Cumberland Pharmaceuticals as of Q2 2016.

Based on PDT Partners's 13F filing for Q2 2016, filed 15 Aug 2016.